neoadjuvant immunochemotherapyNSCLC
…e II, IIIA, and IIIB (N2) NSCLC (AJCC 8th edition) treated with neoadjuvant immunochemotherapy, with or without adjuvant therapy. Baseline characteristics, tr…
Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
This treatment is selected. Its supporting articles are shown below.
…e II, IIIA, and IIIB (N2) NSCLC (AJCC 8th edition) treated with neoadjuvant immunochemotherapy, with or without adjuvant therapy. Baseline characteristics, tr…
…usion, improves MPR prediction in patients with NSCLC receiving neoadjuvant immunochemotherapy, enabling personalized treatment by identifying responders and …